- IBDEI2LV ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,41616,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41616,1,3,0)
- ;;=3^Dysphasia following other cerebrovascular disease
- ;;^UTILITY(U,$J,358.3,41616,1,4,0)
- ;;=4^I69.821
- ;;^UTILITY(U,$J,358.3,41616,2)
- ;;=^5007523
- ;;^UTILITY(U,$J,358.3,41617,0)
- ;;=I69.221^^155^2061^25
- ;;^UTILITY(U,$J,358.3,41617,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41617,1,3,0)
- ;;=3^Dysphasia following oth nontraumatic intracranial hemorrhage
- ;;^UTILITY(U,$J,358.3,41617,1,4,0)
- ;;=4^I69.221
- ;;^UTILITY(U,$J,358.3,41617,2)
- ;;=^5007460
- ;;^UTILITY(U,$J,358.3,41618,0)
- ;;=G11.1^^155^2061^27
- ;;^UTILITY(U,$J,358.3,41618,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41618,1,3,0)
- ;;=3^Early-onset cerebellar ataxia
- ;;^UTILITY(U,$J,358.3,41618,1,4,0)
- ;;=4^G11.1
- ;;^UTILITY(U,$J,358.3,41618,2)
- ;;=^5003753
- ;;^UTILITY(U,$J,358.3,41619,0)
- ;;=I69.392^^155^2061^28
- ;;^UTILITY(U,$J,358.3,41619,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41619,1,3,0)
- ;;=3^Facial weakness following cerebral infarction
- ;;^UTILITY(U,$J,358.3,41619,1,4,0)
- ;;=4^I69.392
- ;;^UTILITY(U,$J,358.3,41619,2)
- ;;=^5007517
- ;;^UTILITY(U,$J,358.3,41620,0)
- ;;=I69.192^^155^2061^29
- ;;^UTILITY(U,$J,358.3,41620,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41620,1,3,0)
- ;;=3^Facial weakness following nontraumatic intcrbl hemorrhage
- ;;^UTILITY(U,$J,358.3,41620,1,4,0)
- ;;=4^I69.192
- ;;^UTILITY(U,$J,358.3,41620,2)
- ;;=^5007454
- ;;^UTILITY(U,$J,358.3,41621,0)
- ;;=I69.292^^155^2061^31
- ;;^UTILITY(U,$J,358.3,41621,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41621,1,3,0)
- ;;=3^Facial weakness following oth nontraumatic intcrn hemorrhage
- ;;^UTILITY(U,$J,358.3,41621,1,4,0)
- ;;=4^I69.292
- ;;^UTILITY(U,$J,358.3,41621,2)
- ;;=^5007486
- ;;^UTILITY(U,$J,358.3,41622,0)
- ;;=I69.092^^155^2061^30
- ;;^UTILITY(U,$J,358.3,41622,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41622,1,3,0)
- ;;=3^Facial weakness following ntrm subarachnoid hemorrhage
- ;;^UTILITY(U,$J,358.3,41622,1,4,0)
- ;;=4^I69.092
- ;;^UTILITY(U,$J,358.3,41622,2)
- ;;=^5007422
- ;;^UTILITY(U,$J,358.3,41623,0)
- ;;=I69.892^^155^2061^32
- ;;^UTILITY(U,$J,358.3,41623,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41623,1,3,0)
- ;;=3^Facial weakness following other cerebrovascular disease
- ;;^UTILITY(U,$J,358.3,41623,1,4,0)
- ;;=4^I69.892
- ;;^UTILITY(U,$J,358.3,41623,2)
- ;;=^5007548
- ;;^UTILITY(U,$J,358.3,41624,0)
- ;;=I69.351^^155^2061^34
- ;;^UTILITY(U,$J,358.3,41624,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41624,1,3,0)
- ;;=3^Hemiplga fol cerebral infrc aff right dominant side
- ;;^UTILITY(U,$J,358.3,41624,1,4,0)
- ;;=4^I69.351
- ;;^UTILITY(U,$J,358.3,41624,2)
- ;;=^5007504
- ;;^UTILITY(U,$J,358.3,41625,0)
- ;;=I69.352^^155^2061^33
- ;;^UTILITY(U,$J,358.3,41625,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41625,1,3,0)
- ;;=3^Hemiplga fol cerebral infrc aff left dominant side
- ;;^UTILITY(U,$J,358.3,41625,1,4,0)
- ;;=4^I69.352
- ;;^UTILITY(U,$J,358.3,41625,2)
- ;;=^5007505
- ;;^UTILITY(U,$J,358.3,41626,0)
- ;;=I69.353^^155^2061^35
- ;;^UTILITY(U,$J,358.3,41626,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41626,1,3,0)
- ;;=3^Hemiplga fol cerebral infrc aff right nondom side
- ;;^UTILITY(U,$J,358.3,41626,1,4,0)
- ;;=4^I69.353
- ;;^UTILITY(U,$J,358.3,41626,2)
- ;;=^5007506
- ;;^UTILITY(U,$J,358.3,41627,0)
- ;;=I69.354^^155^2061^36
- ;;^UTILITY(U,$J,358.3,41627,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41627,1,3,0)
- ;;=3^Hemiplga fol cerebral infrc affecting left nondom side
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2LV 3791 printed Feb 18, 2025@23:57:43 Page 2
- IBDEI2LV ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,41616,1,0)
- +2 ;;=^358.31IA^4^2
- +3 ;;^UTILITY(U,$J,358.3,41616,1,3,0)
- +4 ;;=3^Dysphasia following other cerebrovascular disease
- +5 ;;^UTILITY(U,$J,358.3,41616,1,4,0)
- +6 ;;=4^I69.821
- +7 ;;^UTILITY(U,$J,358.3,41616,2)
- +8 ;;=^5007523
- +9 ;;^UTILITY(U,$J,358.3,41617,0)
- +10 ;;=I69.221^^155^2061^25
- +11 ;;^UTILITY(U,$J,358.3,41617,1,0)
- +12 ;;=^358.31IA^4^2
- +13 ;;^UTILITY(U,$J,358.3,41617,1,3,0)
- +14 ;;=3^Dysphasia following oth nontraumatic intracranial hemorrhage
- +15 ;;^UTILITY(U,$J,358.3,41617,1,4,0)
- +16 ;;=4^I69.221
- +17 ;;^UTILITY(U,$J,358.3,41617,2)
- +18 ;;=^5007460
- +19 ;;^UTILITY(U,$J,358.3,41618,0)
- +20 ;;=G11.1^^155^2061^27
- +21 ;;^UTILITY(U,$J,358.3,41618,1,0)
- +22 ;;=^358.31IA^4^2
- +23 ;;^UTILITY(U,$J,358.3,41618,1,3,0)
- +24 ;;=3^Early-onset cerebellar ataxia
- +25 ;;^UTILITY(U,$J,358.3,41618,1,4,0)
- +26 ;;=4^G11.1
- +27 ;;^UTILITY(U,$J,358.3,41618,2)
- +28 ;;=^5003753
- +29 ;;^UTILITY(U,$J,358.3,41619,0)
- +30 ;;=I69.392^^155^2061^28
- +31 ;;^UTILITY(U,$J,358.3,41619,1,0)
- +32 ;;=^358.31IA^4^2
- +33 ;;^UTILITY(U,$J,358.3,41619,1,3,0)
- +34 ;;=3^Facial weakness following cerebral infarction
- +35 ;;^UTILITY(U,$J,358.3,41619,1,4,0)
- +36 ;;=4^I69.392
- +37 ;;^UTILITY(U,$J,358.3,41619,2)
- +38 ;;=^5007517
- +39 ;;^UTILITY(U,$J,358.3,41620,0)
- +40 ;;=I69.192^^155^2061^29
- +41 ;;^UTILITY(U,$J,358.3,41620,1,0)
- +42 ;;=^358.31IA^4^2
- +43 ;;^UTILITY(U,$J,358.3,41620,1,3,0)
- +44 ;;=3^Facial weakness following nontraumatic intcrbl hemorrhage
- +45 ;;^UTILITY(U,$J,358.3,41620,1,4,0)
- +46 ;;=4^I69.192
- +47 ;;^UTILITY(U,$J,358.3,41620,2)
- +48 ;;=^5007454
- +49 ;;^UTILITY(U,$J,358.3,41621,0)
- +50 ;;=I69.292^^155^2061^31
- +51 ;;^UTILITY(U,$J,358.3,41621,1,0)
- +52 ;;=^358.31IA^4^2
- +53 ;;^UTILITY(U,$J,358.3,41621,1,3,0)
- +54 ;;=3^Facial weakness following oth nontraumatic intcrn hemorrhage
- +55 ;;^UTILITY(U,$J,358.3,41621,1,4,0)
- +56 ;;=4^I69.292
- +57 ;;^UTILITY(U,$J,358.3,41621,2)
- +58 ;;=^5007486
- +59 ;;^UTILITY(U,$J,358.3,41622,0)
- +60 ;;=I69.092^^155^2061^30
- +61 ;;^UTILITY(U,$J,358.3,41622,1,0)
- +62 ;;=^358.31IA^4^2
- +63 ;;^UTILITY(U,$J,358.3,41622,1,3,0)
- +64 ;;=3^Facial weakness following ntrm subarachnoid hemorrhage
- +65 ;;^UTILITY(U,$J,358.3,41622,1,4,0)
- +66 ;;=4^I69.092
- +67 ;;^UTILITY(U,$J,358.3,41622,2)
- +68 ;;=^5007422
- +69 ;;^UTILITY(U,$J,358.3,41623,0)
- +70 ;;=I69.892^^155^2061^32
- +71 ;;^UTILITY(U,$J,358.3,41623,1,0)
- +72 ;;=^358.31IA^4^2
- +73 ;;^UTILITY(U,$J,358.3,41623,1,3,0)
- +74 ;;=3^Facial weakness following other cerebrovascular disease
- +75 ;;^UTILITY(U,$J,358.3,41623,1,4,0)
- +76 ;;=4^I69.892
- +77 ;;^UTILITY(U,$J,358.3,41623,2)
- +78 ;;=^5007548
- +79 ;;^UTILITY(U,$J,358.3,41624,0)
- +80 ;;=I69.351^^155^2061^34
- +81 ;;^UTILITY(U,$J,358.3,41624,1,0)
- +82 ;;=^358.31IA^4^2
- +83 ;;^UTILITY(U,$J,358.3,41624,1,3,0)
- +84 ;;=3^Hemiplga fol cerebral infrc aff right dominant side
- +85 ;;^UTILITY(U,$J,358.3,41624,1,4,0)
- +86 ;;=4^I69.351
- +87 ;;^UTILITY(U,$J,358.3,41624,2)
- +88 ;;=^5007504
- +89 ;;^UTILITY(U,$J,358.3,41625,0)
- +90 ;;=I69.352^^155^2061^33
- +91 ;;^UTILITY(U,$J,358.3,41625,1,0)
- +92 ;;=^358.31IA^4^2
- +93 ;;^UTILITY(U,$J,358.3,41625,1,3,0)
- +94 ;;=3^Hemiplga fol cerebral infrc aff left dominant side
- +95 ;;^UTILITY(U,$J,358.3,41625,1,4,0)
- +96 ;;=4^I69.352
- +97 ;;^UTILITY(U,$J,358.3,41625,2)
- +98 ;;=^5007505
- +99 ;;^UTILITY(U,$J,358.3,41626,0)
- +100 ;;=I69.353^^155^2061^35
- +101 ;;^UTILITY(U,$J,358.3,41626,1,0)
- +102 ;;=^358.31IA^4^2
- +103 ;;^UTILITY(U,$J,358.3,41626,1,3,0)
- +104 ;;=3^Hemiplga fol cerebral infrc aff right nondom side
- +105 ;;^UTILITY(U,$J,358.3,41626,1,4,0)
- +106 ;;=4^I69.353
- +107 ;;^UTILITY(U,$J,358.3,41626,2)
- +108 ;;=^5007506
- +109 ;;^UTILITY(U,$J,358.3,41627,0)
- +110 ;;=I69.354^^155^2061^36
- +111 ;;^UTILITY(U,$J,358.3,41627,1,0)
- +112 ;;=^358.31IA^4^2
- +113 ;;^UTILITY(U,$J,358.3,41627,1,3,0)
- +114 ;;=3^Hemiplga fol cerebral infrc affecting left nondom side
